Validation of MMS Test for Cancer Monitoring

Terminated

• Conditions: Melanoma; Sarcoma; Colo-rectal Cancer; Stomach Cancer

• Registration Number: NCT02113683
• Lead Sponsor: MedInnovation GmbH

Brief Summary

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-04-08
• Study First Submitted QC: 2014-04-10
• Study First Posted: 2014-04-15
• Study Start: 2014-05
• Status Verified: 2018-03
• Primary Completion: 2018-06-20
• Study Completion: 2018-06-20
• Last Update Submitted: 2018-06-20
• Last Update Posted: 2018-06-21

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Clinical diagnosis of colo-rectal cancer
• Clinical diagnosis of stomach cancer
• Suspected diagnosis of melanoma

Exclusion Criteria

• Colitis ulcerosa
• Morbus Crohn
• Cancer in time period two years before
• Cancer therapy in time period two years before

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
active tumor growth before and after cancer therapy	up to 36 month

Trial Locations

Locations (1)

HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie; 🇩🇪 Berlin, Germany